An observational study in Diabetes Mellitus Type 2, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.
Sponsored by National Taiwan University Hospital · Observational
Diabetes mellitus
This study aims to establish both retrospective and prospective cohorts of patients with type 2 diabetes, enabling long-term follow-up of metabolic factors and related complications (such as cardiovascular disease, nephropathy, and neuropathy), as well as changes in nutritional status and physical function (including dietary habits, body composition, and grip strength). The goal is to identify risk factors that influence clinical outcomes and to provide evidence to support individualized treatment and integrated care strategies.
10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 300 across 1,741 observational studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →National Taiwan University Hospital is the lead sponsor of 2,615 studies on the registry; 576 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)
Time frame: Everytime after physician's appointment(Usually 3 months).
Plan to share: Undecided
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Aug 2028, 34 months after the start.
Of 432 non-industry observational studies under Diabetes Mellitus, Type 2, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 96. This study's planned 34 months is close to that.
Counting every sponsor, half of 602 studies reached it within 32 months; a quarter within 17 and three quarters within 62.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital →